Warming the Hands for Raynaud's Phenomenon
Yes, warming the hands is an effective and evidence-based intervention for Raynaud's phenomenon and should be recommended as part of first-line management alongside pharmacologic therapy.
Guideline-Based Recommendations
The most recent 2024 EULAR guidelines explicitly recommend practical advice for patients with Raynaud's phenomenon, including the use of gloves and heating devices for the hands, avoidance of direct contact with cold surfaces, and thorough drying of the skin 1. This represents a formal guideline endorsement of warming strategies as part of comprehensive management.
The evidence supporting this recommendation includes:
- An RCT demonstrating that gloves decrease the burden of Raynaud's phenomenon (Level of Evidence 2) 1
- Recognition that cold exposure is the main exacerbating factor for Raynaud's phenomenon, with patients experiencing more frequent and longer attacks during winter versus summer 1
Clinical Evidence Supporting Hand Warming
Arm/Proximal Heating
The most recent high-quality evidence comes from a 2023 multicentre prospective trial that evaluated continuous heating of the upper arm near the elbow 2. This study of 28 systemic sclerosis patients found:
- Significant reduction in Raynaud Condition Score (1.98 with warming vs 2.66 without, p<0.05)
- Decreased frequency and total duration of Raynaud's attacks
- Simple application of disposable warmers to the upper arm was effective
A 2022 pilot study corroborated these findings, showing that heating the neck or elbows significantly reduced visual analogue scale scores for Raynaud's phenomenon and up-regulated angiopoietin-1 in the fingers, suggesting a biological mechanism for benefit 3.
Direct Hand Warming
Earlier research from 1988 demonstrated that warming hands in hot water for 5 minutes every 4 hours resulted in statistically significant decreases in both the number and duration of Raynaud's attacks, with accompanying increases in blood flow measured by laser-Doppler flowmetry 4.
Practical Implementation Algorithm
For all patients with Raynaud's phenomenon:
Immediate trigger avoidance: Avoid cold exposure and sudden temperature changes
Protective measures: Use gloves routinely, especially in cold environments
Active warming options:
Combine with pharmacotherapy: Warming is adjunctive to, not replacement for, first-line calcium channel blockers (oral nifedipine) as recommended by 2025 EULAR guidelines 6
Important Caveats
Critical distinction for systemic sclerosis patients: While warming helps all Raynaud's patients, those with systemic sclerosis have an inability to maintain nutritive perfusion even with warming due to structural vascular abnormalities, not just sympathetic overactivity 7. These patients require more aggressive pharmacologic management (PDE5 inhibitors, bosentan for digital ulcer prevention) in addition to warming strategies 6.
Warming location matters: Proximal heating (upper arm, elbow, neck) may be as effective or more practical than direct hand warming for sustained benefit 2, 3.
Not a monotherapy: Warming should never be used alone in patients with secondary Raynaud's phenomenon or those with digital ulcers, where vasodilator medications are essential 6.